Monday, June 15, 2026

Samsung Bioepis Launches SBE303: The First ADC Drug Candidate Targeting Nectin-4 in Cancer Trials

Samsung Bioepis has begun Phase 1 trials for its ADC candidate SBE303, targeting solid tumors, set to continue until July 2030.

South Korea Sells $3B in Dollar Bonds at Just 9 bps Over Treasuries — Is the Korea Discount Finally Fading?

South Korea issues $3 billion in FX bonds, signaling a decrease in the Korea discount and boosting foreign exchange reserves.

Kia’s First-Quarter Sales Hit Record High, Thanks to SUV and EV Push

Kia's Q1 sales hit a record 772,351 units, driven by strong SUV demand, despite a dip in South Korea.

Kang Lee

Author's Latest

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.